Bcl-2 and p53 expression in node-negative breast carcinoma: A study with long-term follow-up

This publication has 37 references indexed in Scilit:

• Prognostic value of bcl-2 expression in invasive breast cancer
  British Journal of Cancer, 1995
• bcl‐2 expression in normal breast tissue during the menstrual cycle
  International Journal of Cancer, 1994
• Antibody for detecting p53 protein by immunohistochemistry in normal tissues.
  Journal of Clinical Pathology, 1994
• The Bcl-2 Protein: a Prognostic Indicator Strongly Related to p53 Protein in Lymph Node-Negative Breast Cancer Patients
  JNCI Journal of the National Cancer Institute, 1994
• bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer
  British Journal of Cancer, 1994
• The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status
  Virchows Archiv, 1994
• Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast Cancer
  JNCI Journal of the National Cancer Institute, 1993
• p53 and c-erbB-2 Protein Expression in Breast Carcinomas: An Immunohistochemical Study Including Correlations with Receptor Status, Proliferation Markers, and Clinical Stage in Human Breast Cancer
  American Journal of Clinical Pathology, 1992
• Bcl-2 initiates a new category of oncogenes: regulators of cell death
  Blood, 1992
• p53, guardian of the genome
  Nature, 1992